Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46,377,939
-
Number of holders
-
114
-
Total 13F shares, excl. options
-
20,427,180
-
Shares change
-
+3,149,504
-
Total reported value, excl. options
-
$296,235,043
-
Value change
-
+$42,154,775
-
Put/Call ratio
-
1.45%
-
Number of buys
-
59
-
Number of sells
-
-66
-
Price
-
$14.5
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q1 2017
143 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q1 2017.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 114 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20,427,180 shares
of 46,377,939 outstanding shares and own 44.05% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5,519,038 shares), VANGUARD GROUP INC (2,179,764 shares), STATE STREET CORP (1,062,439 shares), DIMENSIONAL FUND ADVISORS LP (1,061,188 shares), FEDERATED INVESTORS INC /PA/ (1,045,170 shares), ROTHSCHILD ASSET MANAGEMENT INC (624,554 shares), ACADIAN ASSET MANAGEMENT LLC (570,814 shares), TEACHERS ADVISORS, LLC (542,953 shares), Bank of New York Mellon Corp (519,801 shares), and JPMORGAN CHASE & CO (517,900 shares).
This table shows the top 114 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.